1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends

China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

  • February 2017
  • 51 pages
  • International Market Analysis Research and Consult
Report ID: 3451748

Summary

Table of Contents

China currently has the highest number of diabetics in the world. The disease has presently reached epidemic proportions in the adult population. Around three decades ago, less than one percent of the Chinese adult population had diabetes. These levels, however, have increased to around 12 percent - making it the diabetes capital of the world.

The rise of diabetes in China can be attributed to a number of factors. Driven by a strong economic growth over the past few decades, the Chinese population has become richer, fatter and less mobile. Apart from urbanisation and sedentary lifestyles, Chinese people are also genetically more vulnerable to diabetes compared to Europeans and many other population groups. Other factors such as poor awareness of health issues, high consumption of white rice, poor healthcare infrastructure, etc. have also driven the prevalence of the disease.

China’s diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.

IMARC’s new report “China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Chinese diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in China. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Chinese diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the China diabetes market in any form.

What we have achieved in this report?

Comprehensive situation analysis of the Chinese diabetes epidemiology and its dynamics:
Focus of the Analysis:
Historical, current and future prevalence of diabetes in China
Historical, current and future prevalence of type-1 and type-2 diabetes in China
Historical, current and future prevalence of diabetes in the urban and rural regions in China
Historical, current and future prevalence of diabetes among males and females in China
Historical, current and future prevalence of diabetes among various age groups in China
Historical, current and future diagnosis rates for diabetes in China
Historical, current and future drug treatment rates for diabetes in China

Comprehensive situation analysis of the Chinese Oral Antidiabetics market and its dynamics:
Focus of the Analysis:
Performance of the Oral Antidiabetics market in China
Performance of key classes
Performance of key players
Market outlook


Comprehensive situation analysis of the Chinese Insulin market and its dynamics:
Focus of the Analysis:
Performance of the Insulin market in China
Performance of key classes
Performance of key players
Market outlook

Comprehensive situation analysis of the Chinese diabetes diagnostics market and its dynamics:
Focus of the Analysis:
Performance of the diabetes diagnostics market in China
Market Segmentation
Key players
Market outlook                              

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Amrita helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Diabetes Devices market: Asia-Pacific Industry Analysis, Trends, Market Size and Forecasts up to 2023

  • $ 4795
  • Industry report
  • May 2017
  • by Infinium

The study on Diabetes Devices market covers the analysis of global as well as regional markets such as North America, Europe, Asia Pacific, and Rest of the World. According to the report the Diabetes Devices ...

Diabetes Drug Therapy market: Asia-Pacific Industry Analysis, Trends, Market Size and Forecasts up to 2023

  • $ 4795
  • Industry report
  • May 2017
  • by Infinium

The study on Diabetes Drug Therapy market covers the analysis of global as well as regional markets such as North America, Europe, Asia Pacific, and Rest of the World. According to the report the Diabetes ...

Incretion Drugs Markets in China

  • $ 4000
  • Industry report
  • May 2017
  • by Asia Market Information & Development Company

China’s demand for Incretion Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.